Skip to main content

Pritzker Neuropsych Consortium Licenses Ingenuity s Pathway Analysis Software

NEW YORK, March 14 (GenomeWeb News) - The Pritzker Neuropsychiatric Disorders Research Consortium will license Ingenuity's Pathway Analysis software for neuropsychiatric disorder research, Ingenuity said today.

 

The PNDRC will use the newest release of Pathway Analysis to illustrate differences in gene expression and to determine their distribution in neuronal pathways, circuits, and target systems.

 

Financial terms were not disclosed.

 

The PNDRC is a collaborative research enterprise comprising scientific groups at the Universityof Michigan, StanfordUniversity, Universityof Californiaat Irvine, Universityof Californiaat Davis, and Weill Medical College of Cornell University. Its mission is to understand the neurobiology and genetics of mood disorders and schizophrenia.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.